| Value | ₹46.20 Cr |
|---|
BSE filing, NSE: VIJAYA. Summary written from the filing by ALFA Finder's alert engine.
Vijaya Diagnostic Centre Ltd: key numbers
- Share price
- ₹1,442.80
- Market cap
- ₹14,861 Cr
- Revenue (annual)
- ₹814.2 Cr
- Net profit (annual)
- ₹173.0 Cr
- P/E (TTM)
- 79.3×Sector 52.0×
- Promoter holding
- 52.46%-0.05% QoQ
- FII holding
- 10.67%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Vijaya Diagnostic Centre Ltd
All →Vijaya Diagnostic Centre Board Meeting Date
Vijaya Diagnostic Centre scheduled a board meeting for 3 Nov 2026 to approve unaudited Q1 and H1 FY27 results. No financial figures or material decisions are disclosed in this notice.
Vijaya Diagnostic Centre Other Announcement
Vijaya Diagnostic Centre Ltd has filed its quarterly shareholding pattern as mandated by SEBI regulations. This report details the share distribution among various shareholder categories.
Vijaya Diagnostic Centre Annual General Meeting
Vijaya Diagnostic Centre held its 24th Annual General Meeting on September 24, 2026. Shareholders transacted ordinary and special business, including declaring a final dividend.
Vijaya Diagnostic Centre Acquisition
Vijaya Diagnostic Centre is acquiring 100% of Arya Wellness Centre in Guwahati. The company published an investor presentation detailing the acquisition's strategic rationale and financial highlights.
Vijaya Diagnostic Centre Acquisition Worth ₹46.2 Cr
Vijaya Diagnostic Centre Ltd acquired the integrated diagnostic business of Arya Wellness Centre for ₹46.20 Crore. This slump sale expands its presence into the North-East.
- Value
- ₹46.20 Cr
- From
- Arya Wellness Centre
Vijaya Diagnostic Centre Management Change
Vijaya Diagnostic Centre Limited has appointed Dr. Venkata Naresh Yallapragada as the new Chief Information Officer (CIO). This leadership change is effective from September 2, 2026.
Other merger & restructuring announcements
All →Quint Digital Merger & Restructuring
Quint Digital's board approved a Rule 10b5-1 trading plan and the incorporation of a wholly owned overseas subsidiary. No investment amount was disclosed.
Hexaware Technologies Merger & Restructuring
Hexaware Technologies approved a slump sale of its step-down subsidiary Tech SMC Square India to Tech SMC Squared (GCC) India, a related-party deal. Consideration is cash, yet to be set by a registered valuer.
- Execution
- Expected completion by 30 June 2027; agreement date stated as 1 December 2026
Emkay Global Financial Services Merger & Restructuring Worth ₹2.75 Cr
Emkay Global agreed to sell its Wealth Management Business to a step-down subsidiary, Emkay Wealth Advisory, for Rs. 2.75 Crore cash. Completion is expected by 26 January 2027.
- Value
- ₹2.75 Cr
- Execution
- Completion expected by 26 January 2027
TVS Holdings Merger & Restructuring
TVS Holdings forwarded TVS Motor's board outcome of October 28, 2026 approving acquisition of Harita ARC and a composite scheme of amalgamation and demerger. The scheme is subject to stock exchange, SEBI, NCLT and shareholder approvals.
Emkay Global Financial Services Merger & Restructuring Worth ₹30 Cr
Emkay Global approved transferring two subsidiaries to new subsidiary ECPL and slump-selling its wealth business. Up to Rs.30 Crore rights investment in ECPL was also approved.
- Value
- ₹30.00 Cr
- Execution
- Divestment completion expected within 90 days of SPA execution, subject to regulatory approvals
Fortis Healthcare Merger & Restructuring Worth ₹277 Cr
Fortis subsidiary International Hospital acquired Suguna Ramaiah Hospitals' business, operations, land and building for Rs 277 Crore cash. The deal was consummated today, strengthening Bengaluru presence.
- Value
- ₹277.0 Cr